Medical Patent News

RSS

Cellular Origins Launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

A closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labor by 51% and 16-fold, respectively.

From Cellular Origins 31 May 2023

Impaired glucose tolerance and cardiovascular risk factors associated with fertility problems

The present study provided strong evidence that supported the hypothesis that hyperinsulinemia and glucose intolerance cause infertility in women.

31 Jan 2023

Metformin use associated with lower risk of joint replacement in people with type 2 diabetes

Osteoarthritis is a common chronic condition that usually causes joint pain and can be severe enough to require knee and hip replacements.

19 Dec 2022

FIU researchers awarded a U.S. patent for devising methods to synthesize new arsenic-based antibiotic

Florida International University researchers have moved a step closer to producing synthetic arsenic-based drugs in their quest to solve an urgent worldwide health problem -the growing number of infections that have become antibiotic-resistant.

16 Dec 2022

LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

US Patent 11,493,515 will be issued to LSU Health New Orleans on November 8, 2022, for a noninvasive test that more accurately diagnoses a potentially fatal condition in premature infants.

7 Nov 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

New statement assesses the legal hurdles of patent waiver proposal for Covid-19 vaccines

The low level of Covid-19 vaccination in the Global South is ethically unacceptable and risks prolonging the pandemic. The patent waiver in discussion since 2020 within the World Trade Organization (WTO) will not solve these vaccination bottlenecks in the short-term.

14 Dec 2021

World's first patent for AI-generated invention could have repercussions on intellectual property law

Intellectual property officials in South Africa have made history in a landmark decision to award a patent that names an artificial intelligence as the inventor.

29 Jul 2021

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Nanosized molecules of a particular chemical element can inhibit the formation of plaque in the brain tissues. This new discovery by researchers at Umeå University, Sweden, in collaboration with researchers in Croatia and Lithuania, provides renewed hope for novel treatments of, for instance, Alzheimer's and Parkinson's disease in the long run.

1 Jul 2021

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).

23 Jun 2021

ERS Genomics and genOway enter CRISPR/Cas9 agreement

ERS Genomics Limited today announced a non-exclusive license agreement granting genOway past and future access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

7 Jun 2021

STEMI patients with multi-vessel disease have no benefit from FFR-guided PCI

In patients who had a coronary stent inserted after experiencing the most severe type of heart attack, the use of a technique that measures blood flow and pressure through a partially blocked artery to determine if a second stenting procedure is needed did not improve outcomes and was more costly than using angiography, or a heart X-ray, alone to guide the procedure, according to research presented at the American College of Cardiology’s 70th Annual Scientific Session.

17 May 2021

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.

11 Mar 2021

New double-balloon catheter receives Canadian patent

Medical University of South Carolina radiologist assistant Cephus E. Simmons Sr., Ph.D., realized that catheters on the market were not optimal for providing the needed diagnostic yield during radiology procedures.

10 Nov 2020

Patent issued for Concarlo-developed therapeutic peptide to treat drug-resistant breast cancer

Concarlo Holdings LLC, has today announced that US Patent 10,702,570 was issued by the United States Patent and Trademark Office on July 07, 2020, marking the latest step in Concarlo’s journey to commercialize revolutionary medicines for metastatic breast cancer.

30 Jul 2020

New technology for advanced health monitoring of stroke survivors patented in Lithuania

Group of biomedical engineers from biotech company Gruppo Fos Lithuania together with researchers at Kaunas University of Technology and Lithuanian University of Health Sciences have patented technology for advanced health monitoring of stroke survivors.

11 Jul 2020

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

3 Jul 2020

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

The ongoing COVID-19 pandemic has caused nearly five million cases and over 327,000 deaths worldwide. The signs and symptoms of this disease are varied, although there are typical features which assist diagnosis.

20 May 2020

The U.S. can erase cervical cancer in two decades

Cervical cancer is preventable, thanks to the development of the human papillomavirus (HPV) vaccine. Various strains of HPV, a sexually transmitted infection, play a significant role in the event of cervical cancer. Now, the U.S. can eradicate cervical cancer within the next 20 years, according to a new study.

11 Feb 2020

New genetic screen for Huntington’s disease

Huntington’s disease is a genetic disease that is debilitating and progressive leading to severe brain damage and eventual death. In patients with this autosomal dominant disease, there is presence of a protein called the Huntingtin protein that forms clumps within the brain leading to the symptoms of the disease.

30 Jan 2020